CN115315754A - 关注药物或该药物的等效物质的适应症的预测方法、预测装置和预测程序 - Google Patents

关注药物或该药物的等效物质的适应症的预测方法、预测装置和预测程序 Download PDF

Info

Publication number
CN115315754A
CN115315754A CN202180022106.XA CN202180022106A CN115315754A CN 115315754 A CN115315754 A CN 115315754A CN 202180022106 A CN202180022106 A CN 202180022106A CN 115315754 A CN115315754 A CN 115315754A
Authority
CN
China
Prior art keywords
drug
indication
prediction
data
artificial intelligence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180022106.XA
Other languages
English (en)
Chinese (zh)
Inventor
佐藤匠德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infinite Biopharmaceutical Co
Original Assignee
Infinite Biopharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinite Biopharmaceutical Co filed Critical Infinite Biopharmaceutical Co
Publication of CN115315754A publication Critical patent/CN115315754A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/004—Artificial life, i.e. computing arrangements simulating life
    • G06N3/008—Artificial life, i.e. computing arrangements simulating life based on physical entities controlled by simulated intelligence so as to replicate intelligent life forms, e.g. based on robots replicating pets or humans in their appearance or behaviour
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Software Systems (AREA)
  • Computing Systems (AREA)
  • Artificial Intelligence (AREA)
  • Mathematical Physics (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
CN202180022106.XA 2020-01-17 2021-01-15 关注药物或该药物的等效物质的适应症的预测方法、预测装置和预测程序 Pending CN115315754A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-006304 2020-01-17
JP2020006304 2020-01-17
PCT/JP2021/001265 WO2021145434A1 (ja) 2020-01-17 2021-01-15 目的とする薬剤又はその等価物質の適応症の予測方法、予測装置、及び予測プログラム

Publications (1)

Publication Number Publication Date
CN115315754A true CN115315754A (zh) 2022-11-08

Family

ID=76863781

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180022106.XA Pending CN115315754A (zh) 2020-01-17 2021-01-15 关注药物或该药物的等效物质的适应症的预测方法、预测装置和预测程序

Country Status (6)

Country Link
US (1) US20230066502A1 (https=)
JP (1) JPWO2021145434A1 (https=)
CN (1) CN115315754A (https=)
CA (1) CA3167902A1 (https=)
IL (1) IL294698A (https=)
WO (1) WO2021145434A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115486819A (zh) * 2022-11-15 2022-12-20 安徽星辰智跃科技有限责任公司 一种感知觉神经通路多级联检测量化的方法、系统和装置
WO2024178006A1 (en) * 2023-02-21 2024-08-29 Genentech, Inc. Deep learning enabled prediction of drug-induced liver injury

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6559850B1 (ja) 2018-07-27 2019-08-14 Ｋａｒｙｄｏ ＴｈｅｒａｐｅｕｔｉＸ株式会社 ヒトにおける被験物質の作用を予測するための人工知能モデル
EP4047607A4 (en) * 2019-10-17 2022-12-07 Karydo Therapeutix, Inc. ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTING INDICATIONS FOR TEST SUBSTANCES IN HUMANS
JPWO2024202431A1 (https=) 2023-03-31 2024-10-03

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6338538A (ja) 1986-07-31 1988-02-19 Sumitomo Metal Mining Co Ltd ニツケル硫化物からのニツケルの回収方法
AU2001278075A1 (en) * 2000-07-28 2002-02-13 Lion Bioscience Ag Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
EP2180435A4 (en) * 2007-08-22 2011-01-05 Fujitsu Ltd CONNECTIVE PROPERTY PREDICTIVE DEVICE, PROPERTY PRESENCE METHOD AND PROGRAM FOR CARRYING OUT THE METHOD
JP5844715B2 (ja) * 2012-11-07 2016-01-20 学校法人沖縄科学技術大学院大学学園 データ通信システム、データ解析装置、データ通信方法、および、プログラム
WO2016208776A1 (ja) 2015-06-25 2016-12-29 株式会社国際電気通信基礎技術研究所 多器官連関システムを基盤とした予測装置、及び予測プログラム
JP6559850B1 (ja) * 2018-07-27 2019-08-14 Ｋａｒｙｄｏ ＴｈｅｒａｐｅｕｔｉＸ株式会社 ヒトにおける被験物質の作用を予測するための人工知能モデル

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115486819A (zh) * 2022-11-15 2022-12-20 安徽星辰智跃科技有限责任公司 一种感知觉神经通路多级联检测量化的方法、系统和装置
WO2024178006A1 (en) * 2023-02-21 2024-08-29 Genentech, Inc. Deep learning enabled prediction of drug-induced liver injury

Also Published As

Publication number Publication date
US20230066502A1 (en) 2023-03-02
CA3167902A1 (en) 2021-07-22
WO2021145434A1 (ja) 2021-07-22
IL294698A (en) 2022-09-01
JPWO2021145434A1 (https=) 2021-07-22

Similar Documents

Publication Publication Date Title
JP7266899B2 (ja) ヒトにおける被験物質の作用を予測するための人工知能モデル
CN115315754A (zh) 关注药物或该药物的等效物质的适应症的预测方法、预测装置和预测程序
JP7682270B2 (ja) 人工知能を使用して脊髄性筋萎縮症に関する予測結果を生成するための技法
US10553318B2 (en) Individual and cohort pharmacological phenotype prediction platform
US11037070B2 (en) Diagnostic test planning using machine learning techniques
McGeachie et al. The metabolomics of asthma control: a promising link between genetics and disease
CN111164705A (zh) 预测从总群体中任意选择的亚群体中测试对象的不利健康状况的风险、发生或发展的医学设备和计算机实施的方法
US20140089003A1 (en) Patient health record similarity measure
US20140089004A1 (en) Patient cohort laboratory result prediction
EP4047607A1 (en) Artificial intelligence model for predicting indications for test substances in humans
HK40068576A (en) Artificial intelligence model for predicting indications for test substances in humans
EP4297038A1 (en) Method and apparatus for analyzing biomarkers
US20250095800A1 (en) Systems and methods for designing and conducting clinical trials and biomarker validation studies
HK40047964A (en) Artificial intelligence model for predicting effect of test substance on humans
Olanrewaju et al. Machine Learning-Based Prediction of Free IgE Concentration in Allergic Rhinitis Patients Treated with Allergen Immunotherapy and Omalizumab
Baruah et al. in Translational Bioinformatics and Systems

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20221108

WD01 Invention patent application deemed withdrawn after publication